FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/01/101913 [Registered on: 23/01/2026] Trial Registered Prospectively
Last Modified On: 23/01/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A Clinical Study on the Benefits of Adding an Ayurvedic Herbal Medicine to Standard Thyroid Treatment in Hypothyroidism 
Scientific Title of Study   A RANDOMIZED CONTROLLED CLINICAL TRIAL TO STUDY ADJUVANT EFFECT OF INDRAVARUNI MOOL CHURNA WITH LEVOTHYROXINE IN GALAGANDA WITH SPECIAL REFERENCE TO HYPOTHYROIDISM 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sakshi Sudhakar Wasnik 
Designation  Post Graduate Student 
Affiliation  SMBT AYURVED COLLEGE AND HOSPITAL 
Address  Department of Kayachikitsa SMBT AYURVED COLLEGE AND HOSPITAL Dhamangaon, Igatpuri, Nashik

Nashik
MAHARASHTRA
422402
India 
Phone  8847756369  
Fax    
Email  sakshiwasnik03@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Hiraman Warungase 
Designation  HOD and professor 
Affiliation  SMBT AYURVED COLLEGE AND HOSPITAL 
Address  Department of Kayachikitsa SMBT AYURVED COLLEGE AND HOSPITAL Dhamangaon, Igatpuri, Nashik

Nashik
MAHARASHTRA
422402
India 
Phone  9420364157  
Fax    
Email  hiramanwarungase@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sakshi Sudhakar Wasnik 
Designation  Post Graduate Student 
Affiliation  SMBT AYURVED COLLEGE AND HOSPITAL 
Address  Department of Kayachikitsa SMBT AYURVED COLLEGE AND HOSPITAL Dhamangaon, Igatpuri, Nashik

Nashik
MAHARASHTRA
422402
India 
Phone  8847756369  
Fax    
Email  sakshiwasnik03@gmail.com  
 
Source of Monetary or Material Support  
NIL 
 
Primary Sponsor  
Name  Dr Sakshi Wasnik 
Address  SMBT AYURVED COLLEGE AND HOSPITAL Dhamangaon Tal.Igatpuri Dis Nashik 422402 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sakshi Sudhakar Wasnik  SMBT AYURVED COLLEGE AND HOSPITAL   OPD No. 20 Department of Kayachikitsa SMBT AYURVED COLLEGE AND HOSPITAL Dhamangaon, Igatpuri, Nashik
Nashik
MAHARASHTRA 
08847756369

sakshiwasnik03@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
SMBT AYURVED COLLEGE AND HOSPITAL  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:PCS||. Ayurveda Condition: GALAGANDAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Indravaruni Mool Churna, Reference: Bhav Prakash Purva Khanda, Route: Oral, Dosage Form: Churna/ Powder, Dose: 3(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 45 Days, anupAna/sahapAna: Yes(details: Koshna Jala), Additional Information: -
2Comparator Arm (Non Ayurveda)DrugClassical(1) Medicine Name: Levothyroxine, Reference: K D Tripathi, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 25(NA), Frequency: od, Bhaishajya Kal: Abhakta, Duration: 45 Days, anupAna/sahapAna: Yes(details: water), Additional Information: Dose 25-100mcg
3Comparator Arm (Non Ayurveda)Drug-
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients having age group between 18-60 years of either sex.
Patient fulfilling the laboratory diagnosis of hypothyroidism based on the
levels of serum TSH, T3, and T4.
Patients having TSH level less than 20 mIU/L
Patients having uncontrolled TSH level in spite adequate doses of levothyroxine(dose 25 mcg-100mcg)
Patients having signs and symptoms of hypothyroidism 
 
ExclusionCriteria 
Details  Individuals diagnosed with uncontrolled diabetes mellitus, ischemic heart disease, uncontrolled hypertension, myocardial infarction, cerebrovascular incidents, cardiac arrhythmias,and patients with active malignant diseases were not included in the study.
Lactating and pregnant women
Patients having TSH level greater than 20mIUL.
Recent thyroid surgery.
Patients taking dose of levothyroxine 100mcg. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
1 To study the adjuvant effect of indravaruni moola churna with levothyroxine on galaganda  0th 7th 45th day 
 
Secondary Outcome  
Outcome  TimePoints 
NIL  NIL 
 
Target Sample Size   Total Sample Size="70"
Sample Size from India="70" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   09/03/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   A RANDOMIZED CONTROLLED CLINICAL TRIAL TO STUDY ADJUVANT EFFECT OF INDRAVARUNI MOOL CHURNA WITH LEVOTHYROXINE IN GALAGANDA WITH SPECIAL REFERENCE TO HYPOTHYROIDISM
Introduction- The thyroid gland regulates growth, development, and metabolism through T3 and T4 hormones, and hypothyroidism—common in India—results from their deficiency, leading to reduced metabolic activity and myxedema. In Ayurveda, hypothyroidism correlates with Galganda, caused by Kapha and Vata vitiation with Agnimandya. This study aims to assess the adjuvant effect of Indravaruni mool churna, a Kapha-Pittahara drug, in managing Galganda with special reference to hypothyroidism
 Null hypothesis There is no adjuvant effect of Indravaruni mool churna with levothyroxine in galaganda with special reference to Hypothyroidism  
Alternate hypothesis There is adjuvant effect of Indravaruni mool churna with levothyroxine in galaganda with special reference to Hypothyroidism  


 
Close